Literature DB >> 22374498

Getting to the point: what women newly diagnosed with breast cancer want to know about treatment-focused genetic testing.

Bettina Meiser1, Margaret Gleeson, Kaaren Watts, Michelle Peate, Elvira Zilliacus, Kristine Barlow-Stewart, Christobel Saunders, Gillian Mitchell, Judy Kirk.   

Abstract

PURPOSE/
OBJECTIVES: To identify young women's information preferences regarding treatment-focused genetic testing (TFGT) and to develop and evaluate a novel educational resource. RESEARCH APPROACH: Qualitative interview study and pilot testing of a novel resource.
SETTING: Two familial cancer services and one outpatient oncology clinic in Sydney and Melbourne, Australia. PARTICIPANTS: 26 women with breast cancer aged 50 years and younger who either previously had TFGT (n = 14) or had a diagnosis of breast cancer within the previous 6-12 months. METHODOLOGIC APPROACH: Participants were asked about their views of TFGT in semistructured interviews. A brief pamphlet on TFGT then was developed and pilot tested with 17 of the 26 women. MAIN RESEARCH VARIABLES: Women's attitudes and preferences with regard to timing, mode of delivery, and amount and format of information regarding TFGT were explored.
FINDINGS: Most women wanted to be informed about TFGT at or around the time of their cancer diagnosis via a face-to-face consultation. No clear preference existed for which type of healthcare professional should provide information on TFGT. Brief written information about TFGT was viewed as important supporting material. The educational resource developed was well received.
CONCLUSIONS: The potential for more widespread TFGT in the future indicates a need for patient educational materials that enable women to make informed choices about TFGT. This pilot study has provided timely initial evidence on the efficacy of a brief written resource in preparing women for decision making about TFGT.
INTERPRETATION: The resource developed in this study will assist oncology nurses to make important genetic risk information available to women newly diagnosed with breast cancer at a stressful time.

Entities:  

Mesh:

Year:  2012        PMID: 22374498     DOI: 10.1188/12.ONF.E101-E111

Source DB:  PubMed          Journal:  Oncol Nurs Forum        ISSN: 0190-535X            Impact factor:   2.172


  12 in total

1.  Health professionals' evaluation of delivering treatment-focused genetic testing to women newly diagnosed with breast cancer.

Authors:  Kirsten F L Douma; Bettina Meiser; Judy Kirk; Gillian Mitchell; Christobel Saunders; Belinda Rahman; Mariana S Sousa; Kristine Barlow-Stewart; Margaret Gleeson; Kathy Tucker
Journal:  Fam Cancer       Date:  2015-06       Impact factor: 2.375

2.  Development of Breast Cancer Choices: a decision support tool for young women with breast cancer deciding whether to have genetic testing for BRCA1/2 mutations.

Authors:  Chloe Grimmett; Charlotte Brooks; Alejandra Recio-Saucedo; Anne Armstrong; Ramsey I Cutress; D Gareth Evans; Ellen Copson; Lesley Turner; Bettina Meiser; Claire E Wakefield; Diana Eccles; Claire Foster
Journal:  Support Care Cancer       Date:  2018-06-28       Impact factor: 3.603

3.  Are we being overly cautious? A qualitative inquiry into the experiences and perceptions of treatment-focused germline BRCA genetic testing amongst women recently diagnosed with breast cancer.

Authors:  E Zilliacus; B Meiser; M Gleeson; K Watts; K Tucker; E A Lobb; G Mitchell
Journal:  Support Care Cancer       Date:  2012-03-24       Impact factor: 3.603

4.  What men want: Qualitative analysis of what men with prostate cancer (PCa) want to learn regarding genetic referral, counseling, and testing.

Authors:  Samantha Greenberg; Stacey Slager; Brock O' Neil; Kathleen Cooney; Benjamin Maughan; Nicole Stopa; Vickie Venne; Susan Zickmund; Sarah Colonna
Journal:  Prostate       Date:  2020-02-06       Impact factor: 4.104

5.  Intrafamilial disclosure of risk for hereditary breast and ovarian cancer: points to consider.

Authors:  Lee Black; Kelly A McClellan; Denise Avard; Bartha Maria Knoppers
Journal:  J Community Genet       Date:  2012-12-29

6.  How, who, and when: preferences for delivery of genome sequencing results among women diagnosed with breast cancer at a young age.

Authors:  Kimberly A Kaphingst; Jennifer Ivanovich; Ashley Elrick; Rebecca Dresser; Cindy Matsen; Melody S Goodman
Journal:  Mol Genet Genomic Med       Date:  2016-10-24       Impact factor: 2.183

7.  Patients' Views of Treatment-Focused Genetic Testing (TFGT): Some Lessons for the Mainstreaming of BRCA1 and BRCA2 Testing.

Authors:  Sarah Wright; Mary Porteous; Diane Stirling; Julia Lawton; Oliver Young; Charlie Gourley; Nina Hallowell
Journal:  J Genet Couns       Date:  2018-05-11       Impact factor: 2.537

Review 8.  Communication about genetic testing with breast and ovarian cancer patients: a scoping review.

Authors:  Chris Jacobs; Christine Patch; Susan Michie
Journal:  Eur J Hum Genet       Date:  2018-12-20       Impact factor: 4.246

9.  How should we discuss genetic testing with women newly diagnosed with breast cancer? Design and implementation of a randomized controlled trial of two models of delivering education about treatment-focused genetic testing to younger women newly diagnosed with breast cancer.

Authors:  Kaaren J Watts; Bettina Meiser; Gillian Mitchell; Judy Kirk; Christobel Saunders; Michelle Peate; Jessica Duffy; Patrick J Kelly; Margaret Gleeson; Kristine Barlow-Stewart; Belinda Rahman; Michael Friedlander; Kathy Tucker
Journal:  BMC Cancer       Date:  2012-07-28       Impact factor: 4.430

10.  Identifying Needs: a Qualitative Study of women's Experiences Regarding Rapid Genetic Testing for Hereditary Breast and Ovarian Cancer in the DNA BONus Study.

Authors:  Mirjam Tonheim Augestad; Hildegunn Høberg-Vetti; Cathrine Bjorvatn; Ragnhild Johanne Tveit Sekse
Journal:  J Genet Couns       Date:  2016-07-28       Impact factor: 2.537

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.